Brief: Orion And Alligator Bioscience Amend Their Agreement Concerning Two Bispecific Antibodies
19/11/2024 16:35
Nov 19 (Reuters) - Alligator Bioscience AB ATORX.ST :
* REG-ORION AND ALLIGATOR BIOSCIENCE AMEND THEIR AGREEMENT
CONCERNING TWO BISPECIFIC ANTIBODIES
* ORION OYJ - IN CONNECTION WITH AMENDMENT OF AGREEMENT,
ORION
PAYS ALLIGATOR A ONE-TIME PAYMENT OF EUR 3.5 MILLION
Source text: ID:nGNE1FMj17
Further company coverage: ATORX.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln